Invanz
Product Images NDC 0006-3845

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Invanz (NDC 0006-3845). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Images Of Figures 1 And 2 (Invanz 01)

Chemical structure diagram of the active ingredient in INVANZ 1 g, showing the molecular arrangement including rings, hydroxyl, amide, carboxylate, and sodium salt groups.*

FDA Label Image

Images Of Figures 3 And 4 (Invanz 02)

Label for INVANZ 1 g single-dose vials containing ertapenem sodium for intravenous or intramuscular use. Manufactured by Merck Sharp & Dohme LLC, Rahway, NJ, USA, and formulated in France by Fareva Mirabel. The label includes inactive ingredient information, storage instructions, and usage directions.*

FDA Label Image

Images Of Figures 5 And 6 (Invanz 03)

INVANZ 1 g single-dose vial label. The vial contains ertapenem sodium for intravenous or intramuscular use and is labeled for prescription only. The label includes inactive ingredients, manufacturer information as Merck Sharp & Dohme LLC, and states the product is formulated in France. It also features barcodes and batch/expiration date placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.